Measurement uncertainty analysis of low-dose-rate prostate seed brachytherapy: post-implant dosimetry.

The minimal dose covering 90 % of the prostate volume--D 90--is arguably the most important dosimetric parameter in low-dose-rate prostate seed brachytherapy. In this study an analysis of the measurement uncertainties in D 90 from low-dose-rate prostate seed brachytherapy was conducted for two common treatment procedures with two different post-implant dosimetry methods. The analysis was undertaken in order to determine the magnitude of D 90 uncertainty, how the magnitude of the uncertainty varied when D 90 was calculated using different dosimetry methods, and which factors were the major contributors to the uncertainty.

Uncertainties in effective dose estimates of adult CT head scans: the effect of head size.

Purpose: This study is an extension of a previous study where the uncertainties in effective dose estimates from adult CT head scans were calculated using four CT effective dose estimation methods, three of which were computer programs (CT-EXPO, CTDOSIMETRY, and IMPACTDOSE) and one that involved the dose length product (DLP). However, that study did not include the uncertainty contribution due to variations in head sizes.

Methods: The uncertainties due to head size variations were estimated by first using the computer program data to calculate doses to small and large heads.

On the uncertainties in effective dose estimates of adult CT head scans.

Estimates of the effective dose to adult patients from computed tomography (CT) head scanning can be calculated using a number of different methods. These estimates can be used for a variety of purposes, such as improving scanning protocols, comparing different CT imaging centers, and weighing the benefits of the scan against the risk of radiation-induced cancer. The question arises: What is the uncertainty in these effective dose estimates? This study calculates the uncertainty of effective dose estimates produced by three computer programs (CT-EXPO, CTDosimetry, and ImpactDose) and one method that makes use of dose-length product (DLP) values.

Uncertainties of exposure-related quantities in mammographic x-ray unit quality control.

Breast screening programs operate in many countries with mammographic x-ray units subject to stringent quality control tests. These tests include the evaluation of quantities based on exposure measurements, such as half value layer, automatic exposure control reproducibility, average glandular dose, and radiation output rate. There are numerous error sources that contribute to the uncertainty of these exposure-related quantities, some of which are unique to the low energy x-ray spectrum produced by mammographic x-ray units.